1 Introduction to Research & Analysis Reports
1.1 Microneedles for Trans & Intradermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microneedles for Trans & Intradermal Drug Delivery Overall Market Size
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size: 2022 VS 2029
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Microneedles for Trans & Intradermal Drug Delivery Players in Global Market
3.2 Top Global Microneedles for Trans & Intradermal Drug Delivery Companies Ranked by Revenue
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Companies
3.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Companies
3.5 Global Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Microneedles for Trans & Intradermal Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Microneedles for Trans & Intradermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Solid Microneedles
4.1.3 Hollow Microneedles
4.1.4 Dissolvable Microneedles
4.2 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
4.2.1 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2023
4.2.2 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2024-2029
4.2.3 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
4.3.1 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2023
4.3.2 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2024-2029
4.3.3 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
4.4 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Market Size, 2022 & 2029
5.1.2 Drugs
5.1.3 Vaccines
5.1.4 Proteins
5.1.5 Peptides
5.1.6 Others
5.2 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
5.2.1 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2023
5.2.2 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2024-2029
5.2.3 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
5.3.1 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2023
5.3.2 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2024-2029
5.3.3 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
5.4 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Market Size, 2022 & 2029
6.2 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
6.2.1 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2023
6.2.2 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2024-2029
6.2.3 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
6.3.1 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2023
6.3.2 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2024-2029
6.3.3 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.4.2 By Country – North America Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.4.3 US Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.4.4 Canada Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.5.2 By Country – Europe Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.5.3 Germany Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.4 France Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.6 Italy Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.7 Russia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.6.2 By Region – Asia Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.6.3 China Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.4 Japan Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.7 India Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.7.2 By Country – South America Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.7.3 Brazil Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.8.3 Turkey Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8.4 Israel Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8.6 UAE Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Company Summary
7.1.2 Becton Dickinson Business Overview
7.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 Becton Dickinson Key News & Latest Developments
7.2 Nanopass Technologies
7.2.1 Nanopass Technologies Company Summary
7.2.2 Nanopass Technologies Business Overview
7.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Nanopass Technologies Key News & Latest Developments
7.3 Radius Health
7.3.1 Radius Health Company Summary
7.3.2 Radius Health Business Overview
7.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Radius Health Key News & Latest Developments
7.4 Clearside Biomedical
7.4.1 Clearside Biomedical Company Summary
7.4.2 Clearside Biomedical Business Overview
7.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Clearside Biomedical Key News & Latest Developments
7.5 Dr. Prausnitz Group
7.5.1 Dr. Prausnitz Group Company Summary
7.5.2 Dr. Prausnitz Group Business Overview
7.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Dr. Prausnitz Group Key News & Latest Developments
7.6 Zosano Pharma
7.6.1 Zosano Pharma Company Summary
7.6.2 Zosano Pharma Business Overview
7.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Zosano Pharma Key News & Latest Developments
7.7 Corium International
7.7.1 Corium International Company Summary
7.7.2 Corium International Business Overview
7.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Corium International Key News & Latest Developments
7.8 Circassia
7.8.1 Circassia Company Summary
7.8.2 Circassia Business Overview
7.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 Circassia Key News & Latest Developments
7.9 Valeritas, Inc.
7.9.1 Valeritas, Inc. Company Summary
7.9.2 Valeritas, Inc. Business Overview
7.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Valeritas, Inc. Key News & Latest Developments
7.10 BD Medical
7.10.1 BD Medical Company Summary
7.10.2 BD Medical Business Overview
7.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 BD Medical Key News & Latest Developments
8 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity, Analysis
8.1 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity, 2018-2029
8.2 Microneedles for Trans & Intradermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Microneedles for Trans & Intradermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Microneedles for Trans & Intradermal Drug Delivery Supply Chain Analysis
10.1 Microneedles for Trans & Intradermal Drug Delivery Industry Value Chain
10.2 Microneedles for Trans & Intradermal Drug Delivery Upstream Market
10.3 Microneedles for Trans & Intradermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の経皮・皮内薬物送達用マイクロニードル市場予測2023-2029：中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル |
| 【英語タイトル】Microneedles for Trans & Intradermal Drug Delivery Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5288 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：78 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の経皮・皮内薬物送達用マイクロニードル市場規模と予測を収録しています。・世界の経皮・皮内薬物送達用マイクロニードル市場：売上、2018年-2023年、2024年-2029年 ・世界の経皮・皮内薬物送達用マイクロニードル市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の経皮・皮内薬物送達用マイクロニードル市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「中実マイクロニードル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 経皮・皮内薬物送達用マイクロニードルのグローバル主要企業は、Becton Dickinson、 Nanopass Technologies、 Radius Health、 Clearside Biomedical、 Dr. Prausnitz Group、 Zosano Pharma、 Corium International、 Circassia、 Valeritas, Inc.、 BD Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、経皮・皮内薬物送達用マイクロニードルのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の経皮・皮内薬物送達用マイクロニードル市場：タイプ別、2018年-2023年、2024年-2029年 世界の経皮・皮内薬物送達用マイクロニードル市場：タイプ別市場シェア、2022年 ・中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル 世界の経皮・皮内薬物送達用マイクロニードル市場：用途別、2018年-2023年、2024年-2029年 世界の経皮・皮内薬物送達用マイクロニードル市場：用途別市場シェア、2022年 ・医薬品、ワクチン、プロテイン、ペプチド、その他 世界の経皮・皮内薬物送達用マイクロニードル市場：地域・国別、2018年-2023年、2024年-2029年 世界の経皮・皮内薬物送達用マイクロニードル市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル売上、2018年-2023年 ・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル売上シェア、2022年 ・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル販売量、2018年-2023年 ・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Becton Dickinson、 Nanopass Technologies、 Radius Health、 Clearside Biomedical、 Dr. Prausnitz Group、 Zosano Pharma、 Corium International、 Circassia、 Valeritas, Inc.、 BD Medical ************************************************************* ・調査・分析レポートの概要 経皮・皮内薬物送達用マイクロニードル市場の定義 市場セグメント 世界の経皮・皮内薬物送達用マイクロニードル市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の経皮・皮内薬物送達用マイクロニードル市場規模 世界の経皮・皮内薬物送達用マイクロニードル市場規模：2022年 VS 2029年 世界の経皮・皮内薬物送達用マイクロニードル市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの経皮・皮内薬物送達用マイクロニードルの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の経皮・皮内薬物送達用マイクロニードル製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル 経皮・皮内薬物送達用マイクロニードルのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：医薬品、ワクチン、プロテイン、ペプチド、その他 経皮・皮内薬物送達用マイクロニードルの用途別グローバル売上・予測 ・地域別市場分析 地域別経皮・皮内薬物送達用マイクロニードル市場規模 2022年と2029年 地域別経皮・皮内薬物送達用マイクロニードル売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Becton Dickinson、 Nanopass Technologies、 Radius Health、 Clearside Biomedical、 Dr. Prausnitz Group、 Zosano Pharma、 Corium International、 Circassia、 Valeritas, Inc.、 BD Medical ... |
This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery. This report contains market size and forecasts of Microneedles for Trans & Intradermal Drug Delivery in global, including the following market information:
Global Microneedles for Trans & Intradermal Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Microneedles for Trans & Intradermal Drug Delivery Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Microneedles for Trans & Intradermal Drug Delivery companies in 2022 (%)
The global Microneedles for Trans & Intradermal Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Solid Microneedles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia and Valeritas, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microneedles for Trans & Intradermal Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microneedles for Trans & Intradermal Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Global Microneedles for Trans & Intradermal Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Drugs
Vaccines
Proteins
Peptides
Others
Global Microneedles for Trans & Intradermal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microneedles for Trans & Intradermal Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Microneedles for Trans & Intradermal Drug Delivery revenues share in global market, 2022 (%)
Key companies Microneedles for Trans & Intradermal Drug Delivery sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Microneedles for Trans & Intradermal Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Microneedles for Trans & Intradermal Drug Delivery, market overview.
Chapter 2: Global Microneedles for Trans & Intradermal Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microneedles for Trans & Intradermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Microneedles for Trans & Intradermal Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の経皮・皮内薬物送達用マイクロニードル市場予測2023-2029：中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル] (コード：MMG23JU5288)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の経皮・皮内薬物送達用マイクロニードル市場予測2023-2029：中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル]についてメールでお問い合わせ |
